Establishing Clinical Utility Evidence for a Novel Alzheimer's Disease Blood-Based Biomarker Assay

Clinical trial NCT07099001 · COMPLETED

Trial details

NCT number: NCT07099001
Sponsor: Qure Healthcare, LLC
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Alzheimer Disease (AD)Cognitive Decline

Start date: 2025-08-08
Primary completion: 2025-12-31
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.